Nasivin Zonder Conserveermiddelen (Oxymetazoline Hydrochloride)

Oxymetazoline hydrochloride works by selectively activating alpha‑1 and alpha‑2 adrenergic receptors on the blood vessels of the nasal mucosa. This causes vasoconstriction, which reduces swelling and excess fluid in the nasal tissues, thereby decreasing blockage and easing airflow.

The appropriate dose of Nasivin is determined by a qualified healthcare professional. Typically, the prescriber will advise the number of sprays per nostril and the interval between doses, based on the patient’s age, condition and response to treatment.

Safety data for oxymetazoline during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the potential risks and benefits with their physician before using Nasivin.

To order Nasivin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Nasivin contains oxymetazoline, a selective alpha‑adrenergic agonist, which provides rapid vasoconstriction and relief of congestion. Compared with older decongestants such as phenylephrine, oxymetazoline generally offers a longer duration of action and may be effective with fewer doses per day.

Nasivin should be stored at room temperature, away from direct sunlight and moisture. Keep the spray in its original container, ensure the cap is tightly closed when not in use, and avoid exposing the product to extreme temperatures.

Nasivin is administered as a nasal spray. The user tilts the head slightly forward, inserts the nozzle into one nostril, and sprays the prescribed number of sprays while breathing in gently. The process is then repeated in the other nostril if directed by the prescriber.

Serious risks, though uncommon, include elevated blood pressure, cardiac arrhythmias, severe nasal bleeding, allergic reactions such as rash or swelling, and rebound congestion if the product is used for more than three consecutive days.

Nasivin should not be used by children under six years of age, individuals with known hypersensitivity to oxymetazoline or any formulation ingredients, and patients with severe hypertension or certain cardiovascular conditions unless advised by a physician.